Award
Delivery Order #SPE2D326F7509
Short-Term Delivery Order for Vaccine Supply by DMS Pharmaceutical Group
Buyer
Defense Logistics Agency
Award Amount
$309.99
Ceiling
$309.99
Awarded
March 09, 2026
Period of Performance
Mar 09, 2026 – Mar 10, 2026
Identifier
SPE2D326F7509
NAICS
325411
This award is a short-term delivery order contract granted to DMS Pharmaceutical Group Inc., a pharmaceutical manufacturer and distributor specializing in injectable medicines. The contract involves procuring a specific vaccine product, designated as ADACEL TDAP VIAL 0.5ML, to support the government's pharmaceutical needs. The delivery order represents a small-scale, immediate procurement within the framework of a larger long-term Indefinite Delivery Indefinite Quantity (IDIQ) contract held by DMS Pharmaceutical Group, which covers a range of injectable pharmaceuticals over a multi-year period. This arrangement ensures the timely and reliable availability of critical vaccines and medications essential for public health and emergency preparedness. The work under this contract consists of supplying the specified vaccine vial at the designated location in Park Ridge, Illinois, for a brief, clearly defined timeframe. The contract is issued under a competitive or negotiated acquisition process consistent with the parent IDIQ agreement, providing flexibility for government medical supply requirements. The award benefits various government health programs by maintaining continuity in the vaccine supply chain. The contract was recently awarded with performance scheduled to occur within a two-day window, illustrating a rapid procurement cycle for urgent pharmaceutical needs.
Description
4571077917!ADACEL TDAP VIAL 0.5ML